Latest Housing Market News

Reece Limited reported a modest 1% decline in FY25 sales to $9 billion, with earnings pressured by soft housing markets in Australia and the US. Despite operational investments and branch expansions, the company faces a cautious outlook over the next 12-18 months.

Reece Limited reported a 20% decline in EBIT for FY25, reflecting soft demand in both ANZ and US markets despite strategic branch expansions and acquisitions.

Reece Limited reported a modest revenue decline and a sharper drop in profits for FY25, reflecting subdued demand in key markets and ongoing investment in growth. The company declared a reduced fully franked dividend as it navigates a challenging housing environment.

Eureka Group Holdings Limited reported robust FY25 financial results, driven by strong rental demand and strategic acquisitions across Queensland and New South Wales. The company signals continued growth with a significant development pipeline and optimistic FY26 guidance.

Capral Limited reported a solid first half of 2025 with revenue growth despite volume declines, underpinned by higher aluminium prices and a robust balance sheet. The company is advancing its footprint through acquisition and share buy-back initiatives amid cautious market conditions.

RWC reported a 5.5% increase in FY25 net sales driven by the Holman acquisition, while adjusted EBITDA edged up 1.1% amid margin pressures. The company warns of tariff-related cost impacts in FY26, offset by ongoing cost savings and strategic adjustments.

Simonds Group delivered stable FY25 revenue and modest EBITDA growth despite one-off acquisition expenses, positioning itself for growth through strategic product and channel expansion in FY26.

Simonds Group Limited reported steady revenue of $665.6 million for FY2025, alongside a modest net profit of $1.015 million, as it completed the strategic acquisition of Dennis Family Homes. The company is focused on integrating the acquisition and driving growth amid a recovering housing market.

RMA Global Limited has reported its first full year of positive operating cash flow alongside accelerating revenue growth in both the US and ANZ markets, driven by strategic product launches and expanded brokerage partnerships.

Lendlease has expanded its Australian development pipeline with a landmark $2.5 billion luxury residential project at 175 Liverpool Street, Sydney, signaling strong confidence in the high-end market and its strategic growth plans.

Orthocell has marked a pivotal milestone with the first US surgical use of its Remplir™ nerve repair device following FDA clearance, setting the stage for commercial expansion in a $1.6 billion market.

Reece Limited projects FY25 EBIT between A$548m and A$558m, citing ongoing softness in housing markets across Australia, New Zealand, and the US, alongside rising competition in its key US residential construction segment.